|Day Low/High||276.02 / 280.20|
|52 Wk Low/High||208.34 / 305.45|
Watch closely as the government opens a broad antitrust investigation into unidentified leading online technology platforms
WALTHAM, Mass., July 24, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.
Thermo Fisher Scientific revenue expected to rise 3.7% to $6.3 billion.
WALTHAM, Mass., July 11, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.
WALTHAM, Mass., June 28, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Thermo Fisher Scientific Inc has taken over the #18 spot from Take-Two Interactive Software, Inc. , according to ETF Channel.
WALTHAM, Mass., June 24, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.
Jim Cramer looks at retail, specifically the companies that are doing well for working-class Americans, and those that cater to high-end customers -- a 'barbell economy,' he says.
Existing Supply Agreement Remains Intact
The Fed has given retail investors a run around in the past year. Here's the game-plan from here.
WALTHAM, Mass., May 23, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.
Expansion projects will increase single-use capacity to meet growing customer demand
Expands global footprint for complex API manufacturing
WALTHAM, Mass., May 7, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.
WALTHAM, Mass., May 1, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.
WALTHAM, Mass., April 29, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.
Bitcoin, the most famous of all crypto-currencies, has enjoyed something of a rebound of late.
WALTHAM, Mass., April 24, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.
The myriad names in oncology have been the hottest area for acquisitions along with gene therapy.
WALTHAM, Mass., April 1, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.
Apple couldn't do much to hold back the bears today, but Jim Cramer says the company's services segment is the most important thing and he's more than happy with it.
Thermo Fisher Scientific reaches a deal to buy closely held Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies.
U.S. stock futures fall as last week's sharp selloff continues amid concerns over the strength of the world economy and the first inversion of the U.S. Treasury yield curve in more than a decade; the report from Special Counsel Robert Mueller finds the Trump campaign didn't conspire with Russia to swing the 2016 election; Apple is expected Monday to unveil a new subscription video service.
Significantly expands capabilities to support high-growth gene and cell therapy market
PHILADELPHIA, March 19, 2019 /PRNewswire/ -- Pittcon 2019 -- Thermo Fisher Scientific Inc.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.